×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [55]
内容类型
期刊论文 [45]
会议论文 [10]
发表日期
2019 [8]
2018 [10]
2017 [7]
2016 [4]
2015 [17]
2014 [7]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共55条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib
期刊论文
2019, 卷号: 11, 页码: 8191-8200
作者:
Liang Hongge
;
Ma Di
;
Xu Yan
;
Zhao Jing
;
Chen Minjiang
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2020/01/03
crizotinib
echinoderm microtubule-associated protein-like 4–anaplastic lymphoma kinase
lactate dehydrogenase
non-small cell lung cancer
progression-free survival
Using Clinical Indices to Distinguish MODY2 (GCK Mutation) and MODY3 (HNF1A Mutation) from Type 1 Diabetes in a Young Chinese Population
期刊论文
2019, 卷号: 10, 期号: 4, 页码: 1381-1390
作者:
Fu, Junling
;
Wang, Tong
;
Liu, Jieying
;
Wang, Xiaojing
;
Zhang, Qian
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
C-peptide
hsCRP
Lipid
MODY
Type 1 diabetes
Co-mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancer
期刊论文
2019
作者:
Xing Puyuan
;
Han Xiaohong
;
Wang Sha
;
Liu Yutao
;
Yang Sheng
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2020/01/03
circulating tumour DNA
non-small-cell lung cancer
osimertinib
resistance
Trends of Postoperative Radiotherapy for Completely Resected Non-small Cell Lung Cancer in China: A Hospital-Based Multicenter 10-Year (2005-2014) Retrospective Clinical Epidemiological Study
期刊论文
2019, 卷号: 9, 页码: 786
作者:
Men, Yu
;
Wang, Le
;
Zhang, Ye
;
Gao, Shugeng
;
Li, Junling
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2020/01/03
NSCLC
postoperative radiotherapy
trend
epidemiology
multicenter
Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I-III Lung Adenocarcinoma
期刊论文
2019, 卷号: 9, 页码: 556
作者:
Han, Xiaohong
;
Tan, Qiaoyun
;
Yang, Sheng
;
Li, Junling
;
Xu, Jianping
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2020/01/03
lung adenocarcinoma
copy number alteration
prognosis
predict
adjuvant chemotherapy
Clinicopathologic characteristics and outcome of patients with different EGFR mutations
期刊论文
2019, 卷号: 15, 期号: 3, 页码: 166-171
作者:
Zhou, Shengyu
;
Hu, Xingsheng
;
Wang, Yan
;
Li, Junling
;
Zhou, Liqiang
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
EGFR-tyrosine kinase inhibitors
icotinib
nonsmall cell lung cancer
uncommon EGFR mutations
A Phase II Trial of Concurrent Temozolomide and Hypofractionated Stereotactic Radiotherapy for Complex Brain Metastases
期刊论文
2019, 卷号: 24, 期号: 9, 页码: e914-e920
作者:
Bi Nan
;
Ma Yuchao
;
Xiao Jianping
;
Zhang Hongmei
;
Xu Yingjie
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2020/01/03
Complex brain metastasis
Concurrent chemoradiotherapy
Hypofractionated stereotactic radiotherapy
Temozolomide
Birthweight correlates with later metabolic abnormalities in Chinese patients with maturity-onset diabetes of the young type 2
期刊论文
2019, 卷号: 65, 期号: 1, 页码: 53-60
作者:
Fu, Junling
;
Wang, Tong
;
Liu, Jieying
;
Wang, Xiaojing
;
Li, Ming
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2020/01/03
GCK center dot MODY2 center dot Birthweight center dot Metabolic abnormalities
Real world study of the continuation of bevacizumab beyond disease progression after first-line treatment containing bevacizumab in Chinese patients with advanced non-small cell lung cancer
期刊论文
2018, 卷号: 9, 期号: 12, 页码: 1716-1724
作者:
Xing, Puyuan
;
Mu, Yuxin
;
Wang, Yan
;
Hao, Xuezhi
;
Zhu, Yixiang
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
Bevacizumab
beyond progression
non-small cell lung cancer
overall survival
safety
Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study
期刊论文
2018, 卷号: 9, 期号: 11, 页码: 1461-1469
作者:
Cheng, Ying
;
Wang, Yan
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2020/01/03
Clinical practice
epidermal growth factor receptor
mutation
non-small-cell lung cancer
tyrosine kinase inhibitor
©版权所有 ©2017 CSpace - Powered by
CSpace